Silica 99.99% (4N): Specifications, Impurity Limits and Applications

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Glass Beads vs Silica Microspheres: Differences and Uses
  • Keywords: silica wholesale
  • Published: 2026-11-20 05:07:41
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Qiu, Z., Shu, J. & Tang, D. Bioresponsive release system for visual fluorescence detection of carcinoembryonic antigen from mesoporous silica nanocontainers mediated optical color on quantum dot-enzyme-impregnated paper. Anal. Chem. 89, 5152-5160 (2017). Piece CAS PubMed Google Scholar

Foundry Silica Sand: AFS Grain Fineness, Specifications and Uses

Submicron Spherical Silica: Specifications and Uses in Underfill and Advanced Packaging
During the applications of noble metal NPs/MSNs nanocomposites, the corresponding noble metal factors can be properly selected and the aforementioned nanostructured architectures (Types I-V) or some new architectures can be rationally designed, according to the performance requirements and various therapeutic scenarios. For instance, Au NPs are a promising photothermal agent due to their unique localized surface plasmon resonance (LSPR), but the bare Au NPs are not sufficiently stable during light irradiation, and suffer from poor colloidal stability under physiological conditions. To address this issue, a silica-protection strategy was developed, as reported by Duan et al., they coated mesoporous silica shell onto the surface of gold nanorods, and in the meantime additional gold nanoclusters were also incorporated on the surface of the mesoporous silica shell. The resulting core-shelled Au NP/MSNs nanocomposites (Type I architecture) achieved a photothermal conversion efficiency of 77.6%, considerably higher than that of bare gold nanorods. 146 To overcome the cancer multidrug resistance (MDR) and enhance the penetration efficiency of nanomedicines, Kankala et al. designed a zinc metal species modified MSNs nanocarrier (Zn-MSNs), which could effectively disperse ultra-small Pt NPs, and the silica framework structure substantially promoted the loading efficiency of doxorubicin (DOX) (Type II architecture). During treatment, the ultra-small Pt NPs were able to penetrate deep into the tumor under the stimulation of acidic condition, and exhibited the peroxidase-like activity, decomposing hydrogen peroxide (H 2 O 2 ) into toxic hydroxyl radicals (•OH) to kill tumor cells. Importantly, these consequences of the synergistic ablation of MDR cells by ultra-small Pt NPs were favorable only in the presence of the free radical generator, DOX. 147 In addition, to design nanocomposites with high intelligence, e.g., in response to environmental stimuli or with self-propelling characteristic, the nanocomposites, asymmetric Janus-type nanostructures, have been created. Janus Ag/MSNs with SPR impact for pH-responsive drug delivery and SERS imaging, 139 Janus Au/MSNs with the radiation absorption and SPR properties for CT and PA imaging of tumor, 148, 149 and Janus Pt/MSNs as an ultrafast self-propelled motion for smart drug delivery, 150 have been reported successively.
Quartz Powder for Ceramics: Functions, Grades and Particle Size Selection
Singh, A. P., Biswas, A., Shukla, A. & Maiti, P. Targeted therapy in chronic diseases utilizing nanomaterial-based drug delivery vehicles. Signal Transduct. Target Ther. 4, 33 (2019). Post PubMed Central PubMed Google Scholar
Silica Glidant for Tablets: How It Improves Powder Flow and Typical Dosages
Spherical Silica Manufacturer: Key Capabilities, Purity Control and Selection Criteria

Silicon Dioxide in Food: Why It Is Added and Whether It Is Safe

What is silica (SiO₂)?

fumed silica alternative Clinical trials involving mesoporous silica have been ongoing since 2007, discussing its potential in diverse biomedical applications (Table 3 ). To date, the clinical trials have revealed the safety and good tolerability of silica in human subjects. In 2014, MSNs as oral delivery carriers for boosting the pharmacokinetic profile of drugs with limited aqueous solubility were reported. 500 A silica NPs-lipid hybrid formulation loading with ibuprofen (Lipoceramic-IBU) was prepared. The randomized, double-blind, single-dose oral administration study (20 mg ibuprofen) was conducted on 16 healthy male volunteers. The bioavailability of Lipoceramic-IBU was found to be 1.95 times higher than that of the commercial tablet Nurofen. 500 This result suggested the secure and effective use of silica-based NPs in mimicking food impacts to optimize the oral absorption of drugs with poor water solubility. In another clinical trial consisting of 12 participants in 2016, the bioavailability of ordered MSNs-based fenofibrate formulation raised by 54.1% after a single oral dose, when compared to the commercial formulation Lipanthyl. 39 Owing to the potentially perfect clinical outcomes of silica-based nanocarriers, the pharmacokinetics, safety, and metabolic profile of a hybrid core-shell silica NP (named Cornell dots, C dots) with a diameter of 6 nm functionalized with 124 I, targeting peptide cyclo-(Arg-Gly-Asp-Tyr), and Cy5 ( 124 I-cRGDY-PEG-C' dots) is first conducted in humans utilizing PET imaging and clinical tracer at clinical trials in 2014 (NCT01266096). 58 Results showed the good safety and reproducible PK signatures of C dots with the whole-body clearance half-time of 13-21 h after intravenous administration in patients, which is shorter than 111 In labeled liposomes and 131 I-labeled humanized monoclonal antibody A33. These findings verified the possibility of these NPs for cancer diagnostics in humans. 58 Similarly, 8 nm core-shell silica NPs encapsulated with Cy5.5 in the core and connected with cRGDY on the surface (cRGDY-PEG-Cy5.5-nanoparticles) were used in patients at nanomole doses for sentinel lymph nodes detection of head and neck melanoma at a phase 1/2 human clinical trial. 501 The incredible safety, accuracy, reliability, and high contrast of these particles for visual identification of sentinel lymph nodes are irreplaceable by other available imaging molecules presently, of which phase 2 clinical trial is ongoing and will be finished in 2024 (NCT02106598). Meanwhile, another two clinical trials based on C dots are carried out. In 2018, the 89 Zr-DFO-cRGDY-PEG-Cy5-C' dots tracers were first used in both surgical and non-surgical patients for PET-CT imaging of malignant brain tumors in phase 1 clinical trial (NCT03465618). The distribution and removal profiles from the body of these particles will also be assessed till 2023. In 2019, 64 Cu-NOTA-PSMA-PEG-Cy5.5-C' dots tracer was used in another human phase 1 clinical trial for guiding the surgery of prostate cancer by PET and MRI imaging (NCT04167969).As a nanocomposite with high safety and brilliant photothermal conversion efficiency, the silica-gold NPs have also been shown to be potential therapeutic agents for plasmonic photothermal therapy of atherosclerosis (NCT01270139), 502, 503 and photothermal ablation of tumors (NCT00848042, NCT04240639). 40 In addition, an engineered mesoporous silica (SiPore15) with particle size of 1.1-1.5 μm × 0.2-0.4 μm was developed by Baek et al., and they revealed that such pure synthetic amorphous silica could remarkably decrease long-term blood glucose levels, showing good promise for the treatment of prediabetes (NCT03823027). 504 In other clinical trials, an amorphous silica-containing bioactive scaffold, called Siloss, was used to promote bone regeneration, and could be replaced by natural bone due to its fully resorbable nature (NCT02639572), and the silica-calcium phosphate nanocomposite (SCPC) was developed as graft material for the reconstruction of the volume-deficient alveolar ridges (NCT05317039). In all, these clinical trials reveal the safety and efficacy of MSNs in diverse biomedical application scenarios.

What is the difference between fumed silica and precipitated silica?

silica industry outlook

What drives silica raw material prices?

silica supplier USA Lai, C.-Y. et al. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J. Am. Chem. Soc. 125, 4451-4459 (2003). Article CAS PubMed Google Scholar

Cite this article: Silica Raw Materials News. "Silica Manufacturers List: Global and Chinese Producers by Product Type ." Published 2026-11-20 05:07:41. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.